Tom Amick, chairman and CEO of Aldagen, will discuss how his biotechnology firm Aldagen identifies market opportunities and then either acquires an existing firm or creates a new firm to develop the technology to meet those opportunities. He will use his company as an example. You can learn more about his firm by clicking the link below.
Amick will also talk about business ethics, using as his reference his long career with Johnson and Johnson. This session of his talk will focus on J&J’s mission statement.
Date: Thursday, April 3
Time: 6 p.m.
Place: Room 242 KoBC